The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature review

Bao‐Dong Qin(Second Military Medical University), Yuan‐Sheng Zang(Second Military Medical University), Lingyan Yuan(Shanghai Changzheng Hospital), Zhan Wang(Zhejiang Lab), Wenxing Qin(Fudan University Shanghai Cancer Center), Ke Liu(Chinese Academy of Sciences), Xiao‐Dong Jiao(Second Military Medical University)
OncoTargets and Therapy
August 1, 2018
Cited by 33


Related Papers